Opening Up Science
Open access resources and a peer review example for the future of science
licensing
ERS Genomics and Setsuro Tech Sign CRISPR/Cas9 License Agreement
Nobel prize winning CRISPR technology to be applied in development of genetically engineered cell and animal models
ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical
License to Nobel prize-winning CRISPR technology supports internal research and development
ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement
ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models
Expedeon Ag Licenses Lightning-Link Rapid Biotinylation Technology to Cell Guidance Systems
License allows Cell Guidance Systems to use Lightning-Link® in manufacture of TRIFic™ exome detection immunoassay kits
DefiniGEN Licenses ERS Genomics CRISPR Gene Editing Technology
ERS Genomics Limited and DefiniGEN Ltd announced a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents
Isogenica Licenses CIS Display Technology to Aro Biotherapeutics for Centyrin-Based Biopharmaceutical Development
Isogenica has granted a licence to Aro to utilize its proprietary in vitro CIS Display technology
Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement
Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents
Analytical Innovations Bring $10M Back to National Laboratory, Battelle
Advances enhance performance of mass spectrometers.
SAGE Labs Licenses CRISPR/Cas9 Technology from the Broad Institute
The license enables SAGE Labs to use the CRISPR/Cas9 system to engineer cell and animal models for their clients as well as distribute validated CRISPR reagents.